DNA methylation research studies chemical modifications of DNA that influence gene regulation, chromatin state, cellular identity, biological aging, disease mechanisms, and epigenomic biomarkers.
DNA methylation is one of the best-studied epigenomic mechanisms. By adding methyl groups to DNA, especially at CpG sites, cells can regulate gene activity, maintain cellular identity, control developmental programs, and respond to disease-associated regulatory disruption.
At PanorOmics, DNA methylation is presented as a core epigenomics research area: a bridge between genome regulation, gene expression, aging biology, cancer epigenomics, biomarker discovery, and precision medicine.
Studying DNA methylation patterns at CpG sites to understand gene regulation, promoter activity, chromatin state, and cellular identity.
Analyzing how DNA methylation influences transcriptional repression, gene activity, imprinting, and regulatory control.
Investigating methylation changes during development, differentiation, aging, disease progression, and cellular reprogramming.
Using DNA methylation signatures to support disease classification, prognosis, early detection, aging research, and precision medicine studies.
Sequencing-based method that detects methylated cytosines by converting unmethylated cytosines while preserving methylated sites.
Genome-wide DNA methylation profiling that provides high-resolution methylation maps across the entire genome.
Targeted bisulfite sequencing approach that enriches CpG-rich regions for cost-effective methylation analysis.
Array-based platforms used to measure methylation at selected CpG sites across large sample cohorts.
Computational approaches that support methylation signature discovery, epigenetic age prediction, disease classification, and regulatory interpretation.
Measures methylation near gene promoters, often associated with transcriptional repression or altered gene activity.
Analyzes methylation changes at distal regulatory elements that influence cell-type-specific gene expression.
Evaluates genome-wide methylation patterns associated with development, aging, disease, and environmental exposure.
Uses DNA methylation patterns to estimate biological aging and age-associated disease risk.
Identifies tumor-associated methylation changes involved in gene silencing, subtype classification, and biomarker discovery.
Profiles methylation patterns in individual cells to reveal epigenomic heterogeneity and cell-state variation.
Related epigenomic approaches such as chromatin accessibility, disease epigenomics, and histone modification analysis are explored across the Epigenomics Research Center.
Early discoveries established DNA methylation as a chemical modification of DNA with potential regulatory significance.
DNA methylation became strongly linked with gene silencing, genomic imprinting, X-chromosome inactivation, and cancer-associated regulation.
Aberrant promoter methylation emerged as a major mechanism of tumor suppressor gene silencing and cancer epigenomic disruption.
Bisulfite sequencing and methylation arrays enabled genome-wide mapping of DNA methylation across tissues, diseases, and cohorts.
DNA methylation-based clocks connected methylation patterns with biological aging, age-related disease, and lifespan research.
Single-cell methylation methods revealed epigenomic heterogeneity across cells, tissues, tumors, and developmental states.
AI increasingly supports methylation biomarker discovery, epigenetic age modeling, disease classification, and regulatory epigenomics.
Continue exploring the Epigenomics Research Center.
Continue exploring the Epigenomics Research Center.
Continue exploring the Epigenomics Research Center.